IL139731A0 - N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use - Google Patents

N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use

Info

Publication number
IL139731A0
IL139731A0 IL13973199A IL13973199A IL139731A0 IL 139731 A0 IL139731 A0 IL 139731A0 IL 13973199 A IL13973199 A IL 13973199A IL 13973199 A IL13973199 A IL 13973199A IL 139731 A0 IL139731 A0 IL 139731A0
Authority
IL
Israel
Prior art keywords
chloropocainamide
acetyl
methods
acid addition
addition salts
Prior art date
Application number
IL13973199A
Other languages
English (en)
Original Assignee
Oxigene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxigene Inc filed Critical Oxigene Inc
Publication of IL139731A0 publication Critical patent/IL139731A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13973199A 1998-06-08 1999-06-07 N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use IL139731A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/093,474 US6100299A (en) 1996-03-08 1998-06-08 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use
PCT/US1999/012715 WO1999063987A1 (en) 1998-06-08 1999-06-07 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use

Publications (1)

Publication Number Publication Date
IL139731A0 true IL139731A0 (en) 2002-02-10

Family

ID=22239139

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13973199A IL139731A0 (en) 1998-06-08 1999-06-07 N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use

Country Status (8)

Country Link
US (1) US6100299A (xx)
EP (1) EP1083890A4 (xx)
JP (1) JP2002517439A (xx)
AU (1) AU4424799A (xx)
CA (1) CA2334788A1 (xx)
IL (1) IL139731A0 (xx)
WO (1) WO1999063987A1 (xx)
ZA (1) ZA200006840B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713517B1 (en) * 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
SE0002531D0 (sv) * 2000-07-05 2000-07-05 Active Biotech Ab Immune Enhancement
EP1393277B1 (en) 2001-05-21 2006-07-19 Alcon, Inc. USE OF NF-Kappa-B INHIBITORS TO TREAT DRY EYE DISORDERS
US20050269549A1 (en) * 2004-06-02 2005-12-08 Jinhuang Wu Polyol premixes incorporating trans-1, 2-dichloroethylene
MX2021001351A (es) * 2018-08-15 2021-04-13 Pharmacyl Ab Benzamidas sustituidas y su uso en terapia.
BR112021001984A2 (pt) * 2018-08-15 2021-05-11 Pharmacyl Ab composto, combinação, composição farmacêutica, conjunto de partes, uso de composto, e, método para tratamento de uma doença resultante de inflamação patológica
US11717500B2 (en) 2020-02-03 2023-08-08 Pharmacyl Ab Treatment of spondyloarthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2623228C3 (de) * 1976-05-24 1981-09-10 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents

Also Published As

Publication number Publication date
JP2002517439A (ja) 2002-06-18
WO1999063987A1 (en) 1999-12-16
EP1083890A4 (en) 2002-04-24
EP1083890A1 (en) 2001-03-21
ZA200006840B (en) 2001-05-23
CA2334788A1 (en) 1999-12-16
US6100299A (en) 2000-08-08
AU4424799A (en) 1999-12-30

Similar Documents

Publication Publication Date Title
HUP0201633A2 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
GB9907263D0 (en) Amino acid derivatives
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
EP1115389A4 (en) ANTAGONISTS AND AGONISTS OF FRUCTOSAMINE OXIDASE
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
PL345794A1 (en) Aminomethylcarboxylic acid derivatives
IL147216A0 (en) Arylsulfonamido-substituted hydroxamic acid derivatives
HUP0201486A2 (en) Arylmalonic acid dinitrile derivatives, preparation and use thereof
MXPA00012647A (es) Derivados n-sustituidos de acido 5-oxiiminobarbiturico.
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
EP1082466A4 (en) METHOD, REAGENT AND TEST SET FOR TYPING THE GENOME OF PAPILLOMA VIRUS
HK1041827B (zh) 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法
GB2367103B (en) Connector and method of use of the connector
GB9811116D0 (en) Method of altering heartbeat
IL139731A0 (en) N-acetyl 3-chloropocainamide, acid addition salts thereof, and methods of use
HK1045260A1 (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use.
GB9815312D0 (en) Biomas treatment
GB9929979D0 (en) Hydroxamic acid derivatives
PL339336A1 (en) Stable aqueous solution and method of obtaining same
HUP0103309A3 (en) Novel salts of n-tert-butylhydroxylamine and preparation thereof
HUP0102772A3 (en) Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
NO20005164D0 (no) 2-metylpropionsyre-derivater og medisinske sammensetninger inneholdende det samme
HK1025894A1 (en) Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release.